← Back to Patent Explorer
US4440749A Expired / Lapsed US ⏱️ 0.0 years remaining

Preventive and treating agent for blood lipids abnormality and/or arteriosclerosis

Assignee: Kaken Pharmaceutical Co Ltd
•
Filing: 1983-04-12
•
Granted: 1984-04-03
•
Expires: 2003-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A preventive and treating agent for blood lipids abnormally and/or arteriosclerosis comprises a proteolytic enzyme as an effective ingredient.

Inventors

  • 👤 Shigemi Fujisaki
  • 👤 Takashi Fujisaki
  • 👤 Junichi Yoshida
  • 👤 Yasuhiro Fujisaki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 10:57
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/46; A61K38/48; A61K38/482; A61K38/4886; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5036; A61K9/5042; A61P; A61P3/00; A61P3/06; A61P9/00; A61P9/10; C; C12; C12Y; C12Y304/00; C12Y304/24; C12Y304/2404

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 34 words
A method of preventing or treating blood lipids abnormality comprising administering to a patient in need of such therapy an effective amount of pronase or serrathiopeptinase to prevent or treat said blood lipids abnormality.
Claim 2
Independent Claim 34 words
A method of preventing or treating blood lipids abnormality comprising administering to a patient in need of such therapy an effective amount of pronase or serrathiopeptinase to prevent or treat said blood lipids abnormality.
Claim 3
Dependent Claim 16 words
The method of claim 1 wherein pronase is formulated in the form of an enteric preparation.
Claim 4
Dependent Claim 27 words
The method of claim 2 wherein the pronase enteric preparation is orally administered in a dosage of from 10,000 to 500,000 tyrosine units daily for an adult.
Claim 5
Dependent Claim 14 words
The method of claim 1 wherein the blood lipids abnormality is hyperlipemia or hypolipemia.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-04-03 1987-10-03 1988-04-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-04-03 1991-10-03 1992-04-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-04-03 1995-10-03 1996-04-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag